What smart money is saying about The E.W. Scripps Co.
SSP
No fund has written a full thesis on The E.W. Scripps Co. in our archive, but 2 fund letters report a position in it — most recently Gabelli Funds Shareholder Commentary: Open-End Funds in June 2026.
Get an email when a fund writes about it
2
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Every position in The E.W. Scripps Co. on record in the archive was reported in Q2 2026, across 2 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 2 | 0 | 0 | 0 |
Fund activity · 2 positions
- June 2026
“The detractors from performance included Niagen Bioscience Inc. (0.3%) and The E.W. Scripps Co. (0.8%).”
Read the letterThe E.W. Scripps Co. - June 2026
“The detractors from performance included Niagen Bioscience Inc. (0.3%) and The E.W. Scripps Co. (0.8%).”
Read the letterThe E.W. Scripps Co.
Read the letters behind these The E.W. Scripps Co. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger